Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Pharmacology|November 9, 2000
(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in ratsK C Morley, I S McGregorInternal Medicine Journal|November 5, 2016
Alcohol use disorders in AustraliaC H Freyer, K C Morley, P S HaberContemporary Clinical Trials|August 14, 2013
The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trialK C Morley, S Leung, A Baillie, et al.Alcohol, Clinical & Experimental Research|August 13, 2025
Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with alcohol use disorder and liver disease at a liver transplant centerJ Watt, K C Morley, P S Haber, et al.Brain and Behavior|June 25, 2026
Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective OutcomesT Rowe, T Hurzeler, E Towers, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|September 24, 2014
Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid AnxietyK C Morley, A Baillie, S Leung, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|December 18, 2015
Is Specialized Integrated Treatment for Comorbid Anxiety, Depression and Alcohol Dependence Better than Treatment as Usual in a Public Hospital Setting?K C Morley, A Baillie, S Leung, et al.European Journal of Pharmacology|January 5, 2002
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy")K C Morley, J E Gallate, G E Hunt, et al.Pageof 1